Greenwich Lifesciences, Inc. · NASDAQ:GLSI
Patel Snehal bought 3,600 Greenwich Lifesciences, Inc. shares (Form 4)
Traded Jul 23 to Jul 24, 2026 · Filed Jul 27, 2026
From Jul 23 to Jul 24, 2026, Patel Snehal (Director, CEO and CFO, 10% owner) bought 3,600 Greenwich Lifesciences, Inc. shares at an average US$13.06 for US$47,018, leaving 5,607,702 shares. Filed Jul 27, 2026 (Form 4).
- Bought
- 3,600 shares
- Price
- US$13.06 average (US$12.88 to US$13.14)
- Value
- US$47,018
- Holding after
- 5,607,702 shares
- Trading plan
- No
- Role
- Director, CEO and CFO, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 23, 2026 | Common Stock | Buy | 2,500 | US$13.14 | 5,606,602 | Direct |
| Jul 24, 2026 | Common Stock | Buy | 1,100 | US$12.88 | 5,607,702 | Direct |